~~<i id='8812C43EE8'><strike id='8812C43EE8'><tt id='8812C43EE8'><pre id='8812C43EE8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：hotspot 2025-09-29 22:48:30 - browse：7439

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

knowledge

leisure time

entertainment

hotspot

focus

entertainment

BRENDANSMIALOWSKI/viaGettyMuchofthepublic’sperceptionsaroundfoodasaninterventionforhealtharedated.So

WSS

Connecting traumatic brain injury and domestic violence

Bacterial infection may be ‘key event’ in endometriosis, study says

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Women's World Cup brings attention to abuse in soccer

PhRMA sues HHS over Medicare drug price negotiation

These geoengineering technologies could help combat the climate crisis, scientists say

explore

explore

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bacterial infection may be ‘key event’ in endometriosis, study says

The cancer drug shortage isn’t new — and neither are the solutions

Can food be medicine? And other questions about a new push

Malaria cases in Florida and Texas: Here’s what you need to know

Meta looks to target Twitter with a rival app called Threads

The cancer drug shortage isn’t new — and neither are the solutions

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Sports medicine is finally prioritizing gender equality

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

leisure time

Blinken talks high

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Britney Spears to release memoir, 'The Woman In Me,' later this year

When is a doctor not a doctor? Try when patients address women doctors

Antibody drugs appear effective. Now can we make enough of them?

These geoengineering technologies could help combat the climate crisis, scientists say

entertainment

hotspot

focus

entertainment